Compumedics Limited Celebrates Record-Breaking Year

Compumedics Limited (AU:CMP) has released an update.

Compumedics Limited has reported a banner year with record sales orders of approximately $52 million, up 22%, and revenues of $49 million, a 16% increase from the previous year. The growth was driven by strong performance in Australian sleep and neurodiagnostic businesses, new MEG orders in China, and significant sales growth in the US market. Compumedics’ SaaS revenues from Somfit and Nexus 360 also saw a substantial jump to $4.2 million, indicating a promising outlook for the medical device company.

For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.